Status:
UNKNOWN
Urinary Steroid Metabolites in Autism
Lead Sponsor:
Intersci Research Association, Austria
Conditions:
Autism
Autism Spectrum Disorder
Eligibility:
All Genders
5-15 years
Brief Summary
Deviation of hormone formation within nerve cells and nerve system provides autism spectrum disorder and neurodevelopment retardation through interaction of steroids with neurotransmitter-receptors, c...
Detailed Description
Autism spectrum disorder presents many alterations in amino acid metabolism and in neurotransmitter systems (gamma amino acid system, glutamate-glutamine, nicotine-acid, serotonin-system) . Also alter...
Eligibility Criteria
Inclusion
- Autism spectrum disorder
- Age 5-15 years
Exclusion
- Epilepsia
- Psychotropic medication
- other severe illness
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01197131
Start Date
September 1 2010
End Date
April 1 2019
Last Update
February 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intersci Research Association
Leibnitz, Styria, Styria, Austria, 8430